Coxsackievirus A21

DRUG2 trials

Sponsors

Viralytics

Conditions

Malignant MelanomaStage IV Melanoma

Phase 1

Intratumoural Administration of Coxsackievirus A21 for the Control of Malignant Melanoma (PXS-X02)

CompletedNCT00235482

ViralyticsMalignant Melanoma

Start: 2005-11-08End: 2006-04-21Updated: 2019-06-27

A Safety Study of Two Intratumoural Doses of Coxsackievirus Type A21 in Melanoma Patients (PSX-X03)

CompletedNCT00438009

ViralyticsStage IV Melanoma

Start: 2007-05-16End: 2009-08-28Updated: 2019-07-01